![]() |
|
|
|
| | | |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1
.
SEC LITIGATION RELEASE
|
EXTRACTED KEY WORDS
IVES HEALTH COMPANY KEITH IVES CRIMINAL COMPLAINT EXCHANGE COMMISSION DISTRIBUTING DRUG FDA ACCORDING T-FACTOR INVENTOR JAVA PROJECT HEALTH ORGANIZATION IVES HEALTH STOCK PUBLIC STATEMENTS INVESTORS TREATMENT HUMAN IMMUNODEFICIENCY VIRUS EXCHANGE ACT CHARGES KEITH IVES VIOLATION FDA LAW WIRE FRAUD WEBSITE T-CELL HIV-POSITIVE INDIVIDUALS JAKARTA INDONESIA COMPANY ALLEGES |
SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 16957 / April 10, 2001
UNITED STATES v. IVES HEALTH COMPANY AND M. KEITH IVES
01 Mag 0569 (S.D.N.Y.)
Keith Ives, the founder and president of an Oklahoma-based vitamin and
nutritional supplement manufacturer, Ives Health Company, was arrested
on April 4th for fraudulently advertising and distributing a purported
drug for AIDS and HIV. The Commission suspended trading in Ives Health
stock on March 5th because of "questions regarding the accuracy of
public statements by Ives Health to investors concerning, among other
things, a product being marketed by Ives Health for treatment of human
immunodeficiency virus (HIV)." Exchange Act Release No. 44038.
A criminal complaint, unsealed on April 5th, charges Keith Ives and
Ives Health Co. with fraudulently distributing an unapproved new drug,
in violation of FDA law, as well as with wire fraud. According to the
criminal complaint, Ives Health claimed in a press release on February
15th, as well as on its website, that "T-Factor" would increase the
T-cell count of HIV-positive individuals, and had been tested by its
inventor, "Dr. Robert Slayton-Bedeen," in Jakarta, Indonesia. The
so-called "Java Project" was conducted in association with the World
Health Organization, according to the company's claims. The criminal
complaint against Ives and his company alleges, among other things,
that T-Factor was never approved by the FDA, that there is no record
of a "Java Project," and that the World Health Organization is not
aware of the product, its inventor or any testing.
_________________________________________________________________
Modified 04/11/2001
SNIPPETS:
|
| | | |